| 1767 |
36: Inhibition, Aromatase |
21: Altered regulation, Alpha hemoglobin |
Sep 13, 2018 |
Sep 13, 2018 |
None
|
| 2144 |
36: Inhibition, Aromatase |
1789: Reduction, E2 Synthesis by the undifferentiated gonad |
Jun 15, 2020 |
Jul 11, 2022 |
1 AOP
|
| 2167 |
36: Inhibition, Aromatase |
1790: Increased, Differentiation to Testis |
Jul 28, 2020 |
Dec 28, 2022 |
1 AOP
|
| 2350 |
36: Inhibition, Aromatase |
1791: Increased, Male Biased Sex Ratio |
Apr 13, 2021 |
Jan 10, 2023 |
1 AOP
|
| 927 |
41: Inhibition, Bile Salt Export Pump (ABCB11) |
214: Bile accumulation, Pathological condition |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 61 |
51: Inhibition, Ca++ ATPase |
50: Increase, Ca++ (intracellular) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1015 |
980: Inhibition, Calcineurin Activity |
978: Activation, Suppression of NFAT activation and hindrance of nuclear localization |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1254 |
980: Inhibition, Calcineurin Activity |
1202: Suppression, IL-2 and IL-4 production |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1508 |
980: Inhibition, Calcineurin Activity |
979: Interference, nuclear localization of NFAT |
May 19, 2017 |
Jun 27, 2021 |
1 AOP
|
| 3237 |
980: Inhibition, Calcineurin Activity |
2231: Increased, activation of RAAS |
Jun 6, 2024 |
Jun 6, 2024 |
None
|
| 3238 |
980: Inhibition, Calcineurin Activity |
2232: Inhibition, COX-2 activity |
Jun 7, 2024 |
Jun 7, 2024 |
None
|
| 3240 |
980: Inhibition, Calcineurin Activity |
2233: Inhibition, NFAT |
Jun 7, 2024 |
Jun 7, 2024 |
None
|
| 3248 |
980: Inhibition, Calcineurin Activity |
2238: Disrupted calcium-dependent signalling pathway |
Jun 19, 2024 |
Jun 19, 2024 |
None
|
| 1742 |
1522: Inhibition, CHS-1 |
1523: Decrease, Cuticular chitin content |
May 24, 2018 |
Feb 17, 2021 |
2 AOPs
|
| 2170 |
1806: Inhibition, Chitinase |
996: Decrease, Digestion of old cuticle |
Oct 21, 2020 |
Oct 21, 2020 |
1 AOP
|
| 2172 |
1807: Inhibition, Chitobiase |
996: Decrease, Digestion of old cuticle |
Oct 21, 2020 |
Oct 21, 2020 |
1 AOP
|
| 3239 |
2232: Inhibition, COX-2 activity |
2231: Increased, activation of RAAS |
Jun 7, 2024 |
Jun 7, 2024 |
None
|
| 1137 |
1103: Inhibition, Cyclooxygenase 1 activity |
1104: Decreased, Prostaglandin F2alpha concentration, plasma |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 95 |
79: Inhibition, Cyclooxygenase activity |
243: Reduction, Prostaglandin E2 concentration |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 670 |
79: Inhibition, Cyclooxygenase activity |
672: Reduced, Prostaglandin F2alpha synthesis, ovary |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 681 |
79: Inhibition, Cyclooxygenase activity |
681: Decreased, Prostaglandin F2alpha synthesis, ovary |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 686 |
79: Inhibition, Cyclooxygenase activity |
685: Reduced, Prostaglandins, ovary |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 689 |
79: Inhibition, Cyclooxygenase activity |
687: Reduced, Prostaglandin E2 concentration, hypothalamus |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1878 |
1609: Inhibition of Cyp17A1 activity |
1610: Reduction, DHEA |
Apr 10, 2019 |
Apr 10, 2019 |
1 AOP
|
| 1879 |
1609: Inhibition of Cyp17A1 activity |
1611: Reduction, androstenedione |
Apr 10, 2019 |
Apr 10, 2019 |
1 AOP
|